Huawei has launched the 110-inch Smart TV V5 Max with 4K resolution, HarmonyOS 4.5, Honghu AI tech, and immersive audio, ...
Black Diamond Therapeutics and Ideaya Biosciences are mulling over registrational trials for their lead assets after ...
Black Diamond Therapeutics (NASDAQ:BDTX) reported encouraging Phase 2 data for its drug candidate BDTX-1535 in the treatment ...
Black Diamond Therapeutics, Inc. (BDTX) announced positive initial Phase 2 results for BDTX-1535 in patients with relapsed or ...
Shares in Black Diamond Therapeutics rose after the company outlined positive initial data from Phase 2 trials of BDTX-1535, an oral cancer treatment. Shares were up 46% in premarket trading at $6.94.
SB Nation on MSN3d
Mason Black, Camilo Doval make cases for relevance in 2025Mason Black pitched his way to his first career win and Doval regained balance on the 9th’s tightrope for his first save ...
Black Diamond Therapeutics (BDTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Robert Burns from H.C. Wainwright reiterated a Buy rating on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback